Recent studies have demonstrated that TUBA1C is upregulated in different types of cancers, including bladder cancer, breast cancer, and pancreatic ductal adenocarcinoma, and this upregulation is correlated with increased tumor progression and metastasis (16, 35–37). Here, TUBA1C is linked to breast cancer.